| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药主营业务(元) | 4,795,296,414.25 | 9,728,123,365.91 | 5,422,698,599.77 | 11,956,513,829.18 | 6,411,516,229.06 |
| 营业成本(元) | |||||
| 医药主营业务(元) | 3,374,943,082.06 | 7,165,410,160.27 | 4,028,840,831.08 | 9,106,246,189.06 | 4,826,838,444.09 |
| 毛利(元) | |||||
| 医药主营业务(元) | 1,420,353,332.19 | 2,562,713,205.64 | 1,393,857,768.69 | 2,850,267,640.12 | 1,584,677,784.97 |
| 毛利率(%) | |||||
| 医药主营业务(%) | 29.62 | 26.34 | 25.70 | 23.84 | 24.72 |
| 收入构成(%) | |||||
| 医药主营业务(%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| 毛利构成(%) | |||||
| 医药主营业务(%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |